Access Statistics for Katharina Elisabeth Blankart

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Hard Look at “Soft” Cost‐control Measures in Healthcare Organizations: Evidence from Preferred Drug Policies in Germany 0 0 4 10 0 0 7 21
A hard look at soft cost-control measures in healthcare organizations: Evidence from preferred drug policies in Germany 0 0 2 11 0 1 7 33
The Effects of Off-label Drug Use on Disability and Medical Expenditure 0 0 9 9 0 0 8 8
Total Working Papers 0 0 15 30 0 1 22 62


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A structured tool to analyse coverage decisions: Development and feasibility test in the field of cancer screening and prevention 0 0 0 3 0 0 0 78
A systematic review of coverage decision-making on health technologies—Evidence from the real world 0 0 0 20 0 0 0 74
Analysing coverage decision-making: opening Pandora’s box? 0 0 0 3 0 0 0 33
Are patients more adherent to newer drugs? 0 0 0 1 0 0 0 22
Arzneimittel: Placebo bei Engpassbekämpfung 0 0 1 1 0 0 3 3
Dispensing behaviour of pharmacies in prescription drug markets 0 0 0 4 0 0 0 33
Drug safety and the impact of drug warnings: An interrupted time series analysis of diabetes drug prescriptions in Germany and Denmark 0 0 0 1 0 2 2 32
Early Benefit Assessment of Pharmaceuticals in Germany 0 0 0 0 0 0 0 2
Funding Decisions for Newborn Screening: A Comparative Review of 22 Decision Processes in Europe 0 0 0 0 0 0 0 0
Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and Australia 0 0 1 10 0 0 1 50
Link between Process and Appraisal in Coverage Decisions 0 0 0 0 0 0 0 0
Physician-Level Cost Control Measures and Regional Variation of Biosimilar Utilization in Germany 0 0 0 0 0 0 0 0
Regional Innovation Systems of Medical Technology: A knowledge production function of cardiovascular research and funding in Europe 0 0 0 1 0 0 1 4
The diffusion of generics after patent expiry in Germany 0 0 0 7 0 0 0 58
The impact of drug quality ratings from health technology assessments on the adoption of new drugs by physicians in Germany 0 0 0 4 0 0 1 32
The impact of physician-level drug budgets on prescribing behavior 0 0 0 4 0 0 1 22
Transparency vs. closed-door policy: Do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis 0 0 0 5 0 0 0 39
Total Journal Articles 0 0 2 64 0 2 9 482


Statistics updated 2023-05-07